The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Alzheimer’s Disease: Epidemiology and Clinical Progression
Open accessAbstract
Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The diseases encompass various severe conditions, including neurodegenerative disorders like Alzheimer’s disease (AD) [3, 4] and Parkinson’s disease (PD) [5, 6], as well as traumatic brain injuries (TBI) [7] and spinal cord injuries (SCI) [8].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 2×
“4% of all deaths attributable to dementia in 2016 [31].”
Background
Cited by
Sorted by citations
Items 201–300 of 652
Daini, E., Vandini, E., Bodria, M., Liao, W., Baraldi, C., Secco, V., Ottani, A., Zoli, M., Giuliani, D., & Vilella, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1082036 · Cited by 9
Schwinne, M., Alonso, Á., Roberts, B. R., Hickle, S. D., Verberk, I. M. W., Epenge, E., Gikelekele, G., Tshengele, N., Kavugho, I., Mampunza, S. M. M., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230976 · Cited by 8
Analysis of Speech Features in Alzheimer’s Disease with Machine Learning: A Case-Control Study
Noto, S., Sekiyama, Y., Nagata, R., Yamamoto, G., & Tamura, T. (2024) · Healthcare · doi:10.3390/healthcare12212194 · Cited by 9
Natural disaster-induced dementia and cognitive decline: A meta-analysis and systematic review
Thompson, J., & Vasefi, M. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.117898 · Cited by 7
Wang, Z., Liu, J., Chen, F., Wang, W. K., Xu, Y., Lu, F., Li, Y., & Gao, J. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.107926 · Cited by 7
Ambatwar, R., Singh, P., Chandrakar, L., Ghosh, S., Datusalia, A. K., & Khatik, G. L. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130327 · Cited by 7
Mohamed, R. A., Abdelaziz, R. H., Mohamed, M. S., Ahmed, N. H., & Ahmed, R. M. (2025) · Next research. · doi:10.1016/j.nexres.2025.100979 · Cited by 7
Ayyubova, G., Bablu, F. E., Rahimli, N., Aghayeva, L., Springer, E. M., Alghenaim, F., & Suzuki, Y. J. (2026) · Antioxidants · doi:10.3390/antiox15010066 · Cited by 8
Wearable EEG devices in the detection of mild cognitive impairment: a systematic review
He, C., Yu, X., Zhang, Y., Li, Y., & Jiang, N. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02342-w · Cited by 7
Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications
Soni, U., & Pujari, R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111660 · Cited by 7
Advances in the drug treatment of Alzheimer’s disease: pathophysiology and mechanisms of action
Nowell, J., Crook, H., de Leon, M. J., & Edison, P. (2026) · BMJ · doi:10.1136/bmj-2023-078881 · Cited by 7
Lane, H., Wang, S., & Lin, C. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115461 · Cited by 7
Are Ischemic Stroke and Alzheimer’s Disease Genetically Consecutive Pathologies?
Filippenkov, I. B., Владимирович, Х. А., Mozgovoy, I. V., Dergunova, L. V., & Limborska, S. A. (2023) · Biomedicines · doi:10.3390/biomedicines11102727 · Cited by 7
Hashemi, S. A., Ghadimi, Z., Ghaedi, H., & Hashemi, A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148645 · Cited by 7
Wu, L., Jin, L., Li, L., Yu, K., Wu, J., Lei, Y., Jiang, S., & He, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1268566 · Cited by 7
Nayak, A., Raju, R., Das, P., Das, K., Suvitha, A., Meher, B. R., Alobid, S. E., Almoteer, A. I., Almadani, M. E., Alshehri, A., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101888 · Cited by 7
Rudisch, D. M., Krasko, M. N., Barnett, D. G. S., Mueller, K. D., Russell, J. A., Connor, N. P., & Ciucci, M. R. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1294648 · Cited by 7
Atomic Force Microscopy Applied to the Study of Tauopathies
Amorim, M. D. S. D. N., França, Á. R. S., Santos‐Oliveira, R., Sanches, J. R., Melo, T. M., Pinto, B., Barbosa, L. R. S., & Alencar, L. M. R. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00819 · Cited by 7
Gendron, W. A. C., Fertan, E., Roddick, K. M., Wong, A. A., Maliougina, M., Hiani, Y. E., Anini, Y., & Brown, R. E. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114583 · Cited by 7
Jang, H., Na, D. L., Kwon, J. C., Jung, N., Moon, Y., Lee, J. S., Park, K.-W., Lee, A. Y., Cho, H., Lee, J., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230189 · Cited by 7
Al‐Thani, N. A., Zinck, D., Stewart, G. S., & Costello, D. A. (2024) · Metabolites · doi:10.3390/metabo14110634 · Cited by 7
Food Functional Factors in Alzheimer’s Disease Intervention: Current Research Progress
Nie, R., Luo, H.-M., Liu, Y.-P., Wang, S., Hou, Y.-J., Chen, C., Wang, H., Lv, H.-L., Tao, X.-Y., Jing, Z.-H., et al. (2024) · Nutrients · doi:10.3390/nu16233998 · Cited by 7
Piñeiro, M., Manrique, S., Gómez, J., Rodriguez, J. M., Barrera, P., Caballero, D., Sosa, M. A., Vargas-Arana, G., Tapia, A. A., Lima, B., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1508835 · Cited by 7
Ge, W., Yan, Y., Hu, Y., Lin, S., & Mao, P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307246 · Cited by 7
Udayakumar, P., & Subhashini, R. (2025) · Results in Engineering · doi:10.1016/j.rineng.2025.105200 · Cited by 7
Llanos-González, E., Sancho-Bielsa, F. J., Frontiñán-Rubio, J., Rabanal‐Ruiz, Y., García‐Carpintero, S., Chicano‐Gálvez, E., Úbeda‐Bañón, I., Flores‐Cuadrado, A., Giménez‐Llort, L., Alcain, F. J., et al. (2023) · Antioxidants · doi:10.3390/antiox12030747 · Cited by 7
Foster, P. J., Atan, D., Khawaja, A. P., Lotery, A. J., MacGillivray, T., Owen, C. G., Patel, P. J., Petzold, A., Rudnicka, A. R., Sun, Z., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069258 · Cited by 8
Alzheimer Dementia as a Consequence of the Brain Glymphatic System Dysfunction
Shirolapov, I. V., Zakharov, A. V., Bulgakova, S. V., Kulikovskikh, I., Pavlova, O. N., Lyamin, A. V., Smirnova, D. A., & Khivintseva, E. (2023) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2023.14.3.004 · Cited by 7
Naveed, M., Ibrahim, S., Aziz, T. A., Khatoon, K., Asim, M., Majeed, M. N., Hussain, N., Alhomrani, M., Alsanie, W. F., & Alamri, A. S. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416525500085 · Cited by 6
Saleh, R. O., Jabir, M. S., Mohammed, J. S., Ahmad, I. S., Ganesan, S., Shankhyan, A., Nanda, A., Ray, S., Zwamel, A. H., & Hussein, A. R. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70405 · Cited by 6
The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer’s Disease
Katsipis, G., Tzekaki, E. E., Iasonidou, S., & Pantazaki, Α. A. (2025) · Cells · doi:10.3390/cells14181424 · Cited by 6
Astrocyte response in Alzheimer’s disease: Good or bad?
Ismail, A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149971 · Cited by 6
Barbosa, D. B., de Oliveira, L. M. G., Mendes, G. O., Costa, D. B., de Oliveira, T. A., da Silva, M. P., Damázio, L. C. M., Maia, E. H. B., Falkoski, D. L., Marra, I. F. D. S., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c07084 · Cited by 6
Evolutionary sex bias in cognitive response to new environmental risk factor - PM2.5
Chen, H., Verkhratsky, A., Yi, C., & Oliver, B. G. G. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00774-9 · Cited by 7
Tong, P., Li, X., Li, S., Li, S., Chen, B., Chen, D., & Xia, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157591 · Cited by 6
Nasiri, H., Khosravi, F., Saberian, P., Kavian, M., Mozafar, M., Torabi, P., Malekzadeh, T., Hadavi, S. M., Rezaee, A., Ghorbanalinejad, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25694-x · Cited by 6
Zhang, Y., Li, T., Miao, J., Zhang, Z., Yang, M., Wang, Z., Yang, B., Zhang, J., Li, H., Su, Q., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01525 · Cited by 6
Gravandi, M. M., Hosseini, S. Z., Alavi, S. D., Noori, T., Sureda, A., Amirian, R., Farzaei, M. H., & Shirooie, S. (2024) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-142203 · Cited by 6
Zhang, Y., Jiang, J., & Yin, D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1421970 · Cited by 6
Hou, Y., Liu, F., Lin, N., & Gao, S. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07709-z · Cited by 6
Ogunsuyi, O. B., Ogunruku, O. O., Umar, H. I., & Oboh, G. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09712-1 · Cited by 6
Fan, Y., Ling, Y., Hu, J., Hou, Z., Dou, R., & Zhou, C. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.7.23 · Cited by 6
Vagiakis, I., Bakirtzis, C., Andravizou, A., & Pirounides, D. (2024) · Healthcare · doi:10.3390/healthcare12161589 · Cited by 6
Almeaqli, M. T., Alaidaa, Y., Alnajjar, F. M., Shararh, A. S. A., Alharbi, D. S., Almslmani, Y. I., Alotibi, Y. A., Alrashidi, H. S., Alshehri, W. A., Hassan, H. M., et al. (2024) · Current Alzheimer Research · doi:10.2174/0115672050333388240801043509 · Cited by 6
Ekundayo, B. E., Adewale, O. B., Obafemi, B. A., Afolabi, O. B., & Obafemi, T. O. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176958 · Cited by 6
Prejanò, M., Romeo, I., Hernández‐Ayala, L. F., Guzmán‐López, E. G., Alcaro, S., Galano, A., & Marino, T. (2024) · ChemPhysChem · doi:10.1002/cphc.202400653 · Cited by 6
Dysregulated mTOR networks in experimental sporadic Alzheimer’s disease
de la Monte, S. M., & Tong, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1432359 · Cited by 6
Bello-Corral, L., Seco‐Calvo, J., Fresno, Á. M., González, A. I., Llorente, A. M., Fernández‐Lázaro, D., & Sánchez-Valdeón, L. (2024) · Medicina · doi:10.3390/medicina60121941 · Cited by 6
Xu, J., Liu, B., Feng, Z., Yu, X., Shang, G., Liu, Y., Sun, Y., Yang, H., Chen, Y., Zhang, Y., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241297852 · Cited by 6
Detection of fungal sequences in human brain: rDNA locus amplification and deep sequencing
Leitao, R., Wan, I. U., Chown, H., Williams, T. J., Fisher, M. C., & Rhodes, J. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-82840-7 · Cited by 6
Screening properties of the updated normative framework for the Italian MMSE in MCI and dementia
Aiello, E. N., Verde, F., Curti, B., Luca, G. D., Diana, L., Sirtori, M. A., Maranzano, A., Curatoli, C., Zanin, A., Camporeale, E., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-024-07952-4 · Cited by 6
Mohammadi, K., Eskandarpour, V., Nadri, H., Nejabat, M., & Hadizadeh, F. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.142451 · Cited by 6
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
Zhao, Y., & Lukiw, W. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.937961 · Cited by 6
Kirchner, K., Garvert, L., Wittfeld, K., Ameling, S., Bülow, R., zu Schwabedissen, H. E. M., Nauck, M. A., Völzke, H., Grabe, H. J., & der Auwera, S. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021120 · Cited by 6
Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans
de Bruin, H., Groot, C., Kamps, S., Vijverberg, E. G. B., Steward, A., Dehsarvi, A., Pijnenburg, Y. A. L., Ossenkoppele, R., & Franzmeier, N. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf009 · Cited by 5
Integrative machine learning approach to risk prediction for dementia and Alzheimer’s disease
Stern, A., & Linial, M. (2025) · GeroScience · doi:10.1007/s11357-025-01828-x · Cited by 5
Azevedo, C. V., Otaviano, S. F. S. D., Campos, H. C., Figueiredo, E. V., Pereira, A. R., Alves, L., Braga, M., Gimenes, C., Boldarine, V. T., Oyama, L. M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251389824 · Cited by 6
Lv, J., Rani, S., Li, K., & Liu, N. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121739 · Cited by 5
Alzheimer ve Parkinson Hastalıklarında Bor İçeren Bileşiklerin Nörokoruyucu Etkisi
BİTMEZ, B., & Balbal, B. (2024) · Journal of Boron · doi:10.30728/boron.1408368 · Cited by 5
Kushari, S., Saha, D., Kalita, J. M., Kalita, T., Kalita, P., Chakraborty, J., Kumar, S., Das, T., & Patowary, L. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100020 · Cited by 5
Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort
Sikosek, T., Heuvelman, M., Mika, J., Kahraman, M., Jehn, J., Frank, M., Daniel-Moreno, A., Ceiler, J., Skottke, J., Sánchez-Delgado, M., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100257 · Cited by 5
Transformer-Based Deep Learning Approaches for Speech-Based Dementia Detection: A Systematic Review
Mobtahej, P., Gouron, S., Javaheri, R., Le, D. N., El‐Khoury, A., Naing, T. H., & Sajjadi, S. A. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3595781 · Cited by 5
Shi, Y.-S., Zhang, Y., Luo, X. L., Yang, H., & He, Y.-S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02765-2 · Cited by 5
Luengnaruemitchai, G., Kaewmahanin, W., Munthuli, A., Phienphanich, P., Puangarom, S., Sangchocanonta, S., Jariyakosol, S., Hirunwiwatkul, P., & Tantibundhit, C. (2023) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc40787.2023.10340463 · Cited by 5
Rajamanickam, G., & Manju, S. L. (2024) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-024-00207-x · Cited by 5
Assessment of Structural Variations in Fornix of MCI and AD Using MR Images and Geometrical Features
Ali, A., Ronickom, J. F. A., & Swaminathan, R. (2024) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-024-00883-7 · Cited by 5
Classifying Alzheimer's Disease Using a Finite Basis Physics Neural Network
Dhavamani, L., Joshi, S. V., Kothapalli, P. K. V., Muniyandy, E., Ramesh Babu, P., & Selvan, R. S. (2024) · Microscopy Research and Technique · doi:10.1002/jemt.24727 · Cited by 5
Progressing Alzheimer's Diagnosis with Ensemble CNN Model
Yadav, V., Vaibhav, Rohit, R., Kumar, S., & Rastogi, U. (2025) · International Conference on Disruptive Technologies (ICDT) · doi:10.1109/icdt63985.2025.10986459 · Cited by 4
Jazuli, I., Hing, G. B., Selvaratnam, L., Han, L. L., Alex, D., & Kumari, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105764 · Cited by 4
Liu, Y., Aquili, L., Wong, K.-H., Lu, Z.-L., & Lim, L. W. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102755 · Cited by 4
Haji, B., Zhang, Q., & Monfared, A. A. T. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100226 · Cited by 4
Self-citationHu, W., Du, Q., Wei, L., Wang, D., & Zhang, G. (2025) · European journal of medical research · doi:10.1186/s40001-025-03204-z · Cited by 4
Influence of the Gut Microbiota on the Pathogenesis of Alzheimer’s Disease: A Literature Review
Batko, J., Antosz, K., Suchecki, W., Szyller, H. P., Wrześniewska, M., Dyda, M., & Leszek, J. (2025) · Cells · doi:10.3390/cells14201578 · Cited by 4
Liu, J., Zhang, Z., Yu, G., & Han, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70583 · Cited by 5
Reichau, K., Crouzier, L., Gehrig, T., Flake, A., Schaller, E., Meunier, J., Bertrand‐Gaday, C., Chatonnet, A., Zvejniece, L., Sotriffer, C., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118486 · Cited by 4
Kalyanam, B., & Begum, S. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100109 · Cited by 4
Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
Valerio, R. R., Santos, Á. R., Nóbrega, A. H. L., Martins, R., Felice, F. G. D., Ferreira, S. T., Savino, W., Bonomo, A. C., Bernardi, A., & Frozza, R. L. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70341 · Cited by 5
Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
Curd, B. C., Zubrick, C., Brown, C. J. C., Sorweid, M. K., Dehoney, S. B., Anzai, Y., Minoshima, S., Parks, A. L., & Frost, N. A. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70251 · Cited by 4
Kim, S., Kim, M.-J., Kim, J.-S., Jang, J., Choi, W., Lee, H., Song, J.-H., & Hoe, H. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02013-8 · Cited by 4
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Mózes, N., Varga, J. T., Szwajgier, D., Kryczyk‐Poprawa, A., Zábó, V., Lehoczki, A., Lipécz, Á., Csípő, T., Fazekas‐Pongor, V., Major, D., et al. (2026) · Nutrients · doi:10.3390/nu18091470 · Cited by 5
Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 4
Potentiality of Coffee (Coffea robusta) and its Bioactive Compounds in Memory Function: A Review
Ahmad, N., Lesa, K. N., Fakhrudin, N., & Ikawati, Z. (2023) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v7i11.1 · Cited by 4
Palade, J., Alsop, E. B., Courtright-Lim, A., Hsieh, M., Whitsett, T. G., Galasko, D. R., & Keuren‐Jensen, K. R. V. (2024) · Cells · doi:10.3390/cells13030207 · Cited by 4
Enhancing Early Alzheimer's Disease Detection: Leveraging Pre-trained Networks and Transfer Learning
Naveen., N., & Cholli, N. G. (2024) · International Journal of Intelligent Systems and Applications · doi:10.5815/ijisa.2024.01.05 · Cited by 4
Visansirikul, S., Yanaso, S., Boondam, Y., Prasittisa, K., Prutthiwanasan, B., Chongruchiroj, S., & Sripha, K. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00270a · Cited by 4
Efficacy of Acetylcholinesterase Inhibitors in the Logopenic Variant of Primary Progressive Aphasia
Carrier‐Auclair, J., Lavoie, M., Tastevin, M., & Laforce, R. (2024) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000540932 · Cited by 4
The Neuroprotective Role of Tangeritin
Fatima, J., & Siddique, Y. H. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273325789240904065214 · Cited by 4
Macoir, J., Laforce, R. J., & Hudon, C. (2024) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000378 · Cited by 4
Golipoor, M., Rafat, Z., Saberi, A., Roostaei, D., & Shabanpour, A.-M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1477230 · Cited by 4
Chang, Z., Wang, Z., Luo, L., Xie, Z., Yue, C., Bian, X., Yang, H., & Wang, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1423892 · Cited by 4
Merchant, R. A., Dong, Y., Kumari, S., & Murphy, D. P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1540050 · Cited by 4
A concise review of synthetic xanthone derivatives for Alzheimer's disease
Ahmed, L. A., & Sharmah, H. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100256 · Cited by 4
Gürsoy, Ş., Önel, G. T., Türkmenoğlu, B., Merde, İ. B., Dilek, E., Hepokur, C., & Algül, Ö. (2024) · ChemistrySelect · doi:10.1002/slct.202400085 · Cited by 4
Akada, K., Koyama, N., Miura, Y., Takahashi, K., & Aoshima, K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230106 · Cited by 4
Chandler, J., Georgieva, M. V., Desai, U. S., Done, N., Gómez-Liévano, A., Ye, W., Zhao, A., Eid, D., Hilts, A., Kirson, N. Y., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.28 · Cited by 4
Li, Y., Go, M. A., Zhang, H., Aleksynas, R., Kim, J., Gao, M., Prado, S., Sastre, M., & Schultz, S. R. (2026) · Advanced Science · doi:10.1002/advs.77419 · Cited by 3
Kim, T. K., Hong, J., Cho, Y., Jeon, Y., Cho, H., Lee, J., Kim, J., Kim, K. H., Kim, I., Han, S. J., et al. (2025) · Molecules · doi:10.3390/molecules30092030 · Cited by 3
Sun, Y., Lei, X., Lyu, X., Yi, Y., Kan, S.-J., Wang, Z., & Gao, B. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04405-y · Cited by 3
Beneficial Effects of Caraway Oil in Aluminium Chloride-Induced Neurotoxicity
Auti, S. T., & Kulkarni, Y. A. (2025) · Cureus · doi:10.7759/cureus.86783 · Cited by 3
ELÇİ, M. P., ÖREN, S., Salihoğlu, E. M., & Yardım-Akaydin, S. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf130 · Cited by 3
Metadata
- Authors
- Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q.
- Affiliations
- Eisai (United States) (US)
- Venue
- Neurology and Therapy
- Published
- 2022-03-14
- Volume
- 11
- Issue
- 2
- Pages
- 553-569
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- PMC
- PMC9095793
- OpenAlex
- W4221041873
- Cited by
- 629
- References
- 74
- Citations by year
- 2026: 161 · 2025: 208 · 2024: 161 · 2023: 80 · 2022: 19
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neurology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Eisai
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, clinical progression, mild cognitive impairment, amyloid-beta deposition, neurodegeneration, preclinical Alzheimer's disease, disease risk factors, APOE ε4, white matter hyperintensities, entorhinal cortex atrophy, cerebrospinal fluid biomarkers, tau protein, neurogranin, dementia mortality, underdiagnosis, disease-modifying therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
